SK Biopharmaceuticals Revenue

In the year 2025, SK Biopharmaceuticals had annual revenue of 706.74B KRW with 29.06% growth. SK Biopharmaceuticals had revenue of 194.36B in the quarter ending December 31, 2025, with 19.22% growth.

Revenue

706.74B

Revenue Growth

+29.06%

P/S Ratio

11.37

Revenue / Employee

2.87B

Employees

246

Market Cap

8,034.94B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	706.74B	159.14B	29.06%
Dec 31, 2024	547.60B	192.70B	54.30%
Dec 31, 2023	354.89B	108.71B	44.16%
Dec 31, 2022	246.18B	-172.47B	-41.20%
Dec 31, 2021	418.64B	392.65B	1,510.23%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
HLB Co., Ltd.	84.17B
LigaChem Biosciences	141.55B
Peptron	5.63B
Voronoi	7.51B
Samsung Epis Holdings	1,510.14B
OliX Pharmaceuticals	14.67B
D&D Pharmatech	4.30B
SK bioscience	651.37B

Revenue Rankings